Search results
Results from the WOW.Com Content Network
The CJ-100 is supersonic in nearly all flight phases. [1] According to the International Institute for Strategic Studies in 2022, the missile has a range of 2,000 kilometres (1,200 mi; 1,100 nmi). [4]
The Bombardier CRJ100 and CRJ200 (previously Canadair CRJ100 and CRJ200) are regional jets designed and manufactured by Bombardier Aerospace between 1991 and 2006, the first of the Bombardier CRJ family.
The Bombardier CRJ/Mitsubishi CRJ or CRJ Series (for Canadair Regional Jet) is a family of regional jets introduced in 1991 by Bombardier Aerospace.The CRJ was manufactured by Bombardier Aerospace with the manufacturing of the first CRJ generation, the CRJ100/200 starting in 1991 and the second CRJ generation, the CRJ700 series starting in 1999.
Also in 2016, Quizlet launched "Quizlet Live", a real-time online matching game where teams compete to answer all 12 questions correctly without an incorrect answer along the way. [17] In 2017, Quizlet created a premium offering called "Quizlet Go" (later renamed "Quizlet Plus"), with additional features available for paid subscribers.
The CJ-1000A would need 28,200 lbf (125 kN) thrust to replace the CFM LEAP-1C currently used in the Comac C919. The 29,500 lbf (131 kN) variant "CJ-1000B" would be used to power an extended-range C919 variant. [7] In March 2023, reports emerged that the flight test campaign for the CJ-1000A engine had started on a Y-20 test aircraft. [8]
The CJ series are powered by two Williams FJ44 engines; the design uses the Citation II's forward fuselage with a new carry-through section wing and a T-tail. The original CitationJet model has been updated into the CJ1/CJ1+/M2 variants; additionally, the CJ1 was stretched into the CJ2/CJ2+ which was built between 2000 and 2016.
The detonation velocity can be effectively determined by the Chapman–Jouguet (CJ) state, which represents the minimum sustainable steady detonation speed. [7]
Zanamivir is a medication used to treat and prevent influenza caused by influenza A and influenza B viruses.It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings.